These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35970241)

  • 41. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
    Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
    World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
    van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
    United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.
    Tahara T; Yamamoto E; Madireddi P; Suzuki H; Maruyama R; Chung W; Garriga J; Jelinek J; Yamano HO; Sugai T; Kondo Y; Toyota M; Issa JP; Estécio MR
    Gastroenterology; 2014 Feb; 146(2):530-38.e5. PubMed ID: 24211491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers.
    Kim JH; Seo MK; Lee JA; Yoo SY; Oh HJ; Kang H; Cho NY; Bae JM; Kang GH; Kim S
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test Screening.
    Kooyker A; de Jonge L; Toes-Zoutendijk E; Spaander M; van Vuuren H; Kuipers E; van Kemenade F; Ramakers C; Dekker E; Nagtegaal I; van Leerdam M; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3424-3432.e2. PubMed ID: 37619823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
    Burke KE; Nayor J; Campbell EJ; Ananthakrishnan AN; Khalili H; Richter JM
    Dig Dis Sci; 2020 Jan; 65(1):111-118. PubMed ID: 31367882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Prospective Analysis of Meat Mutagens and Colorectal Cancer in the Nurses' Health Study and Health Professionals Follow-up Study.
    Le NT; Michels FA; Song M; Zhang X; Bernstein AM; Giovannucci EL; Fuchs CS; Ogino S; Chan AT; Sinha R; Willett WC; Wu K
    Environ Health Perspect; 2016 Oct; 124(10):1529-1536. PubMed ID: 27105317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.
    Idigoras Rubio I; Arana-Arri E; Portillo Villares I; Bilbao Iturribarrria I; Martínez-Indart L; Imaz-Ayo N; de la Cruz M; de Castro V; López de Munain A; Torrejón Perez I; Gutiérrez-Ibarluzea I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):197-204. PubMed ID: 30543575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study.
    Tran TN; Hoeck S; De Schutter H; Janssens S; Peeters M; Van Hal G
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
    Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
    Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis.
    Singh S; Singh PP; Murad MH; Singh H; Samadder NJ
    Am J Gastroenterol; 2014 Sep; 109(9):1375-89. PubMed ID: 24957158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.
    Hu Y; Ding M; Yuan C; Wu K; Smith-Warner SA; Hu FB; Chan AT; Meyerhardt JA; Ogino S; Fuchs CS; Giovannucci EL; Song M
    Gastroenterology; 2018 Mar; 154(4):916-926.e9. PubMed ID: 29158191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interval Colorectal Cancer 2006-2015: Novel Observations.
    Strum WB; Boland CR
    Dig Dis Sci; 2021 Mar; 66(3):855-860. PubMed ID: 32300937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postcolonoscopy Colorectal Cancer in Sweden From 2003 to 2012: Survival, Tumor Characteristics, and Risk Factors.
    Forsberg A; Widman L; Bottai M; Ekbom A; Hultcrantz R
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2724-2733.e3. PubMed ID: 32553903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity of fecal immunochemical test and risk factors for interval colorectal cancer in a French population.
    Canévet M; Pruvost-Couvreur M; Morvan M; Badic B; Brousse-Potocki J; Kermarrec T; Bouzeloc S; Nousbaum JB; Robaszkiewicz M; Reboux N; Quénéhervé L
    Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102093. PubMed ID: 36764389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of colorectal cancer at different screening intervals after index colonoscopy and post-polypectomy: a meta-analysis of 811,181 participants.
    Zhang Y; Wang X; Zhang W; Zhou X; Ren M; Chen H; Pan H
    Expert Rev Gastroenterol Hepatol; 2022; 16(11-12):1101-1114. PubMed ID: 36408602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.